BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 10553733)

  • 1. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.
    Pierri JN; Chaudry AS; Woo TU; Lewis DA
    Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex.
    Cruz DA; Eggan SM; Lewis DA
    J Comp Neurol; 2003 Oct; 465(3):385-400. PubMed ID: 12966563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia.
    Woo TU; Whitehead RE; Melchitzky DS; Lewis DA
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5341-6. PubMed ID: 9560277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D; Austin M; Pierri J; Sampson A; Lewis D
    Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional specificity of chandelier neuron axon terminal alterations in schizophrenia.
    Konopaske GT; Sweet RA; Wu Q; Sampson A; Lewis DA
    Neuroscience; 2006; 138(1):189-96. PubMed ID: 16337746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex.
    Erickson SL; Lewis DA
    J Comp Neurol; 2002 Jun; 448(2):186-202. PubMed ID: 12012429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.
    Akil M; Pierri JN; Whitehead RE; Edgar CL; Mohila C; Sampson AR; Lewis DA
    Am J Psychiatry; 1999 Oct; 156(10):1580-9. PubMed ID: 10518170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus.
    Lewis DA; Cruz DA; Melchitzky DS; Pierri JN
    Am J Psychiatry; 2001 Sep; 158(9):1411-22. PubMed ID: 11532725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):270-6. PubMed ID: 10719153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chandelier cell axons are immunoreactive for GAT-1 in the human neocortex.
    DeFelipe J; González-Albo MC
    Neuroreport; 1998 Feb; 9(3):467-70. PubMed ID: 9512391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia.
    Cruz DA; Weaver CL; Lovallo EM; Melchitzky DS; Lewis DA
    Neuropsychopharmacology; 2009 Aug; 34(9):2112-24. PubMed ID: 19322171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia.
    Rocco BR; DeDionisio AM; Lewis DA; Fish KN
    Biol Psychiatry; 2017 Jul; 82(1):40-48. PubMed ID: 27884423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.
    Volk DW; Pierri JN; Fritschy JM; Auh S; Sampson AR; Lewis DA
    Cereb Cortex; 2002 Oct; 12(10):1063-70. PubMed ID: 12217970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytic processes compensate for the apparent lack of GABA transporters in the axon terminals of cerebellar Purkinje cells.
    Ribak CE; Tong WM; Brecha NC
    Anat Embryol (Berl); 1996 Oct; 194(4):379-90. PubMed ID: 8896702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyramidal neuron local axon terminals in monkey prefrontal cortex: differential targeting of subclasses of GABA neurons.
    Melchitzky DS; Lewis DA
    Cereb Cortex; 2003 May; 13(5):452-60. PubMed ID: 12679292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal and glial localization of GAT-1, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex.
    Conti F; Melone M; De Biasi S; Minelli A; Brecha NC; Ducati A
    J Comp Neurol; 1998 Jun; 396(1):51-63. PubMed ID: 9623887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats.
    Bloomfield C; French SJ; Jones DN; Reavill C; Southam E; Cilia J; Totterdell S
    Synapse; 2008 Aug; 62(8):628-31. PubMed ID: 18512213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of possible markers for chandelier cartridges in rat medial prefrontal cortex and hippocampus.
    Hardwick C; French SJ; Southam E; Totterdell S
    Brain Res; 2005 Jan; 1031(2):238-44. PubMed ID: 15649449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU
    Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction.
    Volk DW; Lewis DA
    Physiol Behav; 2002 Dec; 77(4-5):501-5. PubMed ID: 12526990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.